Alzheimer's disease drug development pipeline: 2020

INTRODUCTION: Alzheimer's disease (AD) is a growing public health concern affecting millions of patients worldwide and costing billions of dollars annually. We review the pipeline of drugs and biologics in clinical trials for the treatment of AD. We use the Common Alzheimer's and Related D...

Descripción completa

Detalles Bibliográficos
Autores principales: Cummings, Jeffrey, Lee, Garam, Ritter, Aaron, Sabbagh, Marwan, Zhong, Kate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364858/
https://www.ncbi.nlm.nih.gov/pubmed/32695874
http://dx.doi.org/10.1002/trc2.12050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364858/
https://www.ncbi.nlm.nih.gov/pubmed/32695874
http://dx.doi.org/10.1002/trc2.12050

Ejemplares similares